2-Bromo-5-Chloro-Thiazole

What Factors Govern Palladium Retention in Suzuki Cross-Coupling Streams Used for Antiviral Pre-API Synthesis?

The preparation of 5-chloro-2-(4-fluorophenyl)thiazole, a key scaffold incorporated into non-nucleoside hepatitis C virus NS5B polymerase inhibitors, begins with a palladium-catalysed Suzuki-Miyaura cross-coupling between 2-bromo-5-chloro-thiazole (1.0 eq) and 4-fluorophenylboronic acid (1.05 eq) in a deoxygenated 4:1 v/v mixture of 1,4-dioxane and deionised water. A typical charge for a 200 L glass-lined reactor (Pfaudler AE-series, retreat-curve impeller) employs K₃PO₄ (2.0 eq) as base and PdCl₂(dppf)·CH₂Cl₂ at a loading of just 0.005 eq to maintain mass efficiency while meeting the oral permitted daily exposure for palladium. Reaction mass temperature is ramped to 85 °C over 45 min under a nitrogen headspace purge maintaining dissolved oxygen below 20 ppb; process analytical technology (ReactIR 45m) tracks the boronic acid consumption until the content of residual starting material falls below 0.5 area% by HPLC (USP <621>, C18 column, acetonitrile/0.1% phosphoric acid gradient). Once endpoint is reached the batch is cooled to 50 °C, passed through a Celite⁠-545 bed, and the organic layer is agitated for 1 h with a thiol-functionalised silica scavenger (SiliaMetS Thiol, loading 5 wt% relative to theoretical product mass) to capture dissolved palladium species; this intervention consistently delivers a palladium residue below 10 ppm as measured by ICP-MS according to USP <233>, aligning with the ICH Q3D Option 1 oral limit. After scavenger removal and concentration under vacuum, crude product is crystallised from isopropanol/water (3:1) at a cooling rate of 0.2 °C/min, isolated in a Hastelloy C-22 centrifuge under nitrogen blanketing, and dried in a double-cone vacuum dryer at 40 °C until loss-on-drying is below 0.1%. The validated process yields an off-white crystalline solid with 99.5 area% purity and an isolated yield of 88 ± 2%. Bottlenecks observed during tech transfer include batch-to-batch variance in boronic acid anhydride content, which when exceeding 3 wt% generates a desbromo impurity exceeding 1.2%, requiring freshly ground and titre-adjusted boronic acid for consistent performance. The resulting pre-API intermediate is stored under argon at 2–8 °C and is supplied under a Drug Master File framework compliant with ICH Q7 and FDA 21 CFR Part 211 for Phase IIb clinical campaigns.

In agrochemical discovery, the rapid assembly of secondary amine-linked 5-chlorothiazole arrays for oomycete-active fungicide leads typically employs a Buchwald-Hartwig amination between 2-bromo-5-chloro-thiazole and diverse anilines under anhydrous, oxygen-depleted conditions. For kilogram-scale delivery of a candidate targeting plasmopara viticola control, a representative charge combines the thiazole (1.0 eq) with 3,5-dichloroaniline (1.1 eq), Pd₂(dba)₃ (0.01 eq), Xantphos (0.025 eq), and sodium tert-butoxide (1.4 eq) in toluene that has been dried over molecular sieves to a water content below 50 ppm. Operation is conducted in a 50 L 316L stainless-steel reactor fitted with a mechanical double-tandem stirrer and a glycol cooling jacket, purged with 5.0-grade nitrogen before charging; after a 110 °C reflux hold of 18 h, the dark reaction mass is cooled, quenched with degassed deionised water, and the organic phase is treated with a trimethyltriazine-functionalised metal scavenger (QuadraPure TU) for 2 h. Palladium content in the isolated toluene stream is reduced to typically 3–8 ppm—well within the OECD GL 78 recommendation for metal impurities in experimental pesticide active ingredients. Following activated carbon polishing, vacuum distillation, and recrystallisation from n-heptane/ethyl acetate (9:1), the resulting N-aryl-5-chlorothiazol-2-amine is obtained as a pale yellow solid exceeding 98.0 area% by GC-FID (ASTM D3524 mod.) in a yield range of 72–78%. Process robustness is limited by the thermal lability of the Xantphos ligand above 115 °C, which triggers Pd-black formation and irreversible catalyst deactivation; precisely maintaining the jacket temperature at 108 ± 2 °C during the exotherm phase is critical for batch homogeneity. The compound serves as a non-classical lipophilic amide precursor for oxathiapiprolin-analogue discovery, and five batches manufactured under this protocol provided the pre-requisite data package for EPA 40 CFR Part 158 Tier I mammalian toxicology submission.

Electronic-Grade Donor-Acceptor Thiazole-Thiophene Monomer Feedstocks

A Stille coupling protocol leveraging the higher reactivity of the bromine leaving group over chlorine enables the synthesis of 2-(thiophen-2-yl)-5-chlorothiazole, an electron-deficient monomer unit utilised in narrow-bandgap conjugated copolymers for organic photovoltaic (OPV) acceptor domains. Preparation is executed in flame-dried 500 mL Schlenk glassware under a purified argon atmosphere (O₂ < 1 ppm, H₂O < 0.5 ppm) with 2-bromo-5-chloro-thiazole (1.0 eq), 2-tributylstannylthiophene (1.0 eq, distilled under high vacuum), and Pd(PPh₃)₄ (0.015 eq) in anhydrous toluene (10 volumes). After a 48 h reflux period (115 °C oil bath), the mixture is cooled, diluted with ethyl acetate, and stirred with 10 wt% aqueous potassium fluoride for 12 h to precipitate tributyltin fluoride. The organic layer is separated, washed until neutral, dried over MgSO₄, and concentrated; the crude solid is purified by column chromatography (silica gel, n-hexane/CH₂Cl₂ 4:1) followed by train sublimation at 10⁻³ mbar and 65 °C. The final crystalline monomer exhibits a GC purity of 99.97% and a tin residue below 1 ppm as mandated by semiconductor-grade specifications—any residual halogen or organotin chain-terminator raises the polydispersity index of the finished donor-acceptor copolymer beyond 2.5, degrading charge mobility in inverted P3HT-analogue blends. Sublimed material is handled exclusively inside a glovebox (MBraun, H₂O < 0.1 ppm) and characterised by differential scanning calorimetry (DSC, heating rate 10 K/min, melting endotherm onset 88.3 °C) and Karl Fischer coulometry. Suppliers of this monomer must furnish a certificate of compliance with RoHS Directive 2011/65/EU, verifying cadmium, mercury, and restricted phthalates are absent, and test reports in accordance with IEC 62321-7-1:2015 for tin extraction. The ultimate application—slot-die-coated OPV acceptor layers on flexible PET substrates—demands that the monomer retains oven stability for 72 h at 60 °C under nitrogen; degradation above 0.3% as per ISO 11358-1 thermogravimetric analysis triggers batch rejection.

Sequential Thioetherification-Oxidation Produces a Sulfonyl Chlorothiazole Equivalent for Selective COX-2 Inhibition

Introduction of a thioether group via nucleophilic displacement of the bromine atom on 2-bromo-5-chloro-thiazole constitutes the first stage in constructing a methylsulfonyl-substituted heterocycle used as a central hinge binding motif in cyclooxygenase-2 inhibitors structurally related to etoricoxib. A 100 L glass-lined reactor is charged with sodium thiomethoxide (20 wt% aqueous solution, 1.15 eq NaSMe), ethanol (8 volumes), and the thiazole; the mixture is maintained at 25 ± 2 °C with pH monitoring, avoiding acidic swings that would evolve methanethiol volatiles. Conversion is complete within 2 h, delivering 2-methylthio-5-chlorothiazole after vacuum distillation (58–60 °C at 5 mbar) as a colourless liquid with 96% isolated yield and a purity of 99.0 area%. Oxidation to the sulfone is carried out immediately in a 50 L Hastelloy C-276 reactor to withstand the exothermic peroxide decomposition pathway; tungsten disodium triperoxide hydrate catalyst (0.02 eq) is dissolved in water, followed by stepwise addition of 35 wt% hydrogen peroxide (2.3 eq) while rigorously controlling internal temperature at 0–5 °C with a secondary-zone safety shut-off at 8 °C. After 6 h post-addition stirring, excess peroxide is quenched with sodium sulfite, and the precipitated crude sulfone is filtered, washed with ice-cold water, and recrystallised from ethyl acetate/cyclohexane to give 2-methylsulfonyl-5-chlorothiazole in 84% yield (99.3% HPLC purity). A critical quality attribute under ICH M7 is the stringent limit of methyl methanesulfonate, monitored by LC-MS/MS at a threshold of 15 ppm; the recrystallisation solvent ratio and cooling ramp must be precisely controlled to purge this sulfonate ester impurity below the reporting limit. The sulfone intermediate is subsequently elaborated to a drug substance precursor under ICH Q1A stability conditions, and its supply for Phase III registration batches rests on documented oxidative reaction hazard assessments compliant with OSHA 29 CFR 1910.119 process safety management.

When Glycolate Nucleophiles Replace Bromine in Low-Temperature Alkylation: a Route to Oxazole Safener Analogues

Alkylation of ethyl glycolate with 2-bromo-5-chloro-thiazole under strong anhydrous basic conditions yields a chloro-thiazolyloxyacetate ester, which serves as the penultimate intermediate for dichloroacetamide-type herbicide safeners evaluated in maize–chloroacetamide tank mixtures. A 30 L Pfaudler reactor, dried and purged with nitrogen, is charged with sodium hydride (60% mineral oil dispersion, 1.2 eq) and anhydrous THF (6 volumes); the suspension is cooled to 0–5 °C, and neat ethyl glycolate (1.3 eq) is added dropwise over 45 min to control hydrogen evolution. After the alkoxide forms over 30 min, a THF solution of the thiazole is fed at a rate holding the internal temperature below 5 °C, then the batch is warmed to 22 °C and stirred for 16 h. Quenching into saturated ammonium chloride, extracting with ethyl acetate, and washing the organic layer with brine and water removes sodium salts and trace mineral oil derived from the NaH vehicle; the organic concentrate is short-path distilled (102–105 °C at 1.2 mbar) to afford (5-chlorothiazol-2-yloxy)acetic acid ethyl ester as a colourless oil with 98.5% purity by GC and an isolated yield of 82%. Residual mineral oil that partitions into the product can suppress subsequent amine condensation, so an additional filtration through basic alumina is deployed when the oil carryover exceeds 0.5 wt%. The resulting ester is deprotected and condensed with N,N-diallyl-2,2-dichloroacetamide backbone synthons to generate safener candidates that up-regulate glutathione S-transferase in maize; regulatory toxicology packages for these safener uses require a residue definition and analytical enforcement method under EPA 40 CFR Part 180, referencing CIPAC Method MT 46 for formulation content. The intermediate itself must be stored in amber glass under nitrogen at 2–8 °C to suppress ester hydrolysis; its shipment under a REACH-registered substance identity profile (EC inventory) meets EU agrochemical import documentation standards.

A tubular microreactor campaign isolating the lithio intermediate at −78 °C affords 2-functionalised-5-chlorothiazoles for contract research supply. When conventional batch lithiation of 2-bromo-5-chloro-thiazole is executed in a stirred glass reactor, the rapid bromine–lithium exchange with n-butyllithium (1.6 M in n-hexane) liberates sufficient heat to raise the local temperature by 12–18 °C within seconds, generating up to 5% of ring-opened byproducts and limiting scalability to a few hundred grams. The flow chemistry alternative pre-cools separate THF streams of the thiazole (0.25 M) and n-BuLi solution in a Corning Advanced-Flow G1 SiC reactor, contacting them in a T-mixer followed by a 1.2 mL residence-time module at an internal temperature logged at −78 ± 0.3 °C with a calibrated thermocouple. After a residence time of 0.8 s, the lithiated thiazole stream reacts with a pre-chilled neat electrophile—dimethylformamide (DMF) for aldehyde introduction—inside a second heart-shaped mixer, discharging the quenched solution into a stirred aqueous quench at 0 °C. The resulting 5-chloro-thiazole-2-carbaldehyde is isolated by continuous extraction (KARR column) and purified by batch vacuum distillation, delivering 92% isolated yield and 99.4% anhydrous purity, with overall throughput of 4.5 kg/week when operating on a 168 h schedule. This protocol essentially eliminates the thermal runaway hazard, reduces the lithium and bromide waste streams to a single aqueous phase, and ensures batch-to-batch NMR fingerprint consistency (DMSO‑d₆, 500 MHz) exceeding a spectral match factor of 0.98. Built under ISO 9001:2015 quality management, the campaign delivers milligram-to-kilogram quantities for discovery and preclinical development, with each lot accompanied by a full impurity profile compliant with ICH Q3A and a certificate of analysis reporting trace-levels of residual n-butane and hexane by headspace GC-MS per USP <467>.